Amalgamated Bank An2 Therapeutics, Inc. Transaction History

Amalgamated Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$7.94 - $15.6 $674 - $1,326	-85 Reduced 4.59%	1,767 $17,000
Q4 2022 Feb 10, 2023	BUY	$8.51 - $19.69 $3,846 - $8,899	452 Added 32.29%	1,852 $18,000
Q3 2022 Nov 09, 2022	BUY	$7.61 - $22.29 $45 - $133	6 Added 0.43%	1,400 $24,000
Q2 2022 Aug 15, 2022	BUY	$7.7 - $18.82 $10,733 - $26,235	1,394 New	1,394 $11,000

13.5M

Ticker ANTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,402,700
Market Cap $24.4M
Description
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.